ESTRO Brachytherapy for Prostate Cancer 2018
The rate of intraprostatic relapses after primary EBRT is still not negligible:
• 20-40% (20-25.000 failure/year)
• 60% - 72% of patients with negative metastatic workup and rising PSA after RT will have positive prostatic biopsies
Zelefsky et al. Int. J. Radiat. Biol. Phys. 1998 Zagars et al. Int. J. Radiat. Biol. Phys. 1995 Pollack et al. Int. J. Radiat. Biol. Phys. 2002
Crook et al. Cancer. 1997 Alongi et al. CROH. 2013
Made with FlippingBook - Online catalogs